(MENAFN- GlobeNewsWire - Nasdaq) Wilmington, Delaware, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Allied market Research published a report, titled, " Bio Decontamination Market by Product (Equipment and Consumables), by Agent (Hydrogen Peroxide, Chlorine Dioxide and Nitrogen Dioxide), Type (Chamber Decontamination and Room Decontamination), and End User (Pharmaceutical and Biotechnology Companies and Healthcare Facilities): Global Opportunity Analysis and industry Forecast, 2024-2033" . According to the report, the bio decontamination market was valued at $229.5 million in 2023, and is estimated to reach $525.4 million by 2033, growing at a CAGR of 8.7% from 2024 to 2033.
Request Sample of the Report on Bio Decontamination Market 2033 -
Prime Determinants of Growth
Increase in awareness of the importance of maintaining sterile environments in healthcare and pharmaceutical industries is a major driver for the bio decontamination market. In healthcare settings, the rise of hospital-acquired infections (HAIs) has resulted in the critical need for stringent sterilization protocols to protect patients and healthcare workers. Pharmaceutical industries demand highly sterilized environments to ensure the safety and efficacy of their products, as any contamination leads to costly recalls and endangers public health. This heightened awareness has led to the adoption of advanced bio decontamination technologies, which effectively eliminate pathogens and ensure sterile conditions. The ongoing focus on improving infection control measures and maintaining high standards of cleanliness continues to propel the growth of the bio decontamination market, reflecting its essential role in safeguarding health and safety in these critical sectors. In addition, the growing pharmaceutical and biopharmaceutical industry is a major driver for the bio decontamination market. As these industries expand, the demand for stringent contamination control measures increases to ensure product safety and regulatory compliance. High standards in manufacturing environments necessitate effective bio decontamination solutions to eliminate microbial contamination.
Report Coverage & Details
| Repot Coverage | Details |
| Forecast Period | 2024–2033 |
| Base Year | 2023 |
| Market Size in 2023 | $229.5 million |
| Market Size in 2033 | $525.4 million |
| CAGR | 8.7% |
| No. of Pages in Report | 280 |
| Segments Covered | Product, Agent, Type, End User, and Region |
| Drivers | Increasing awareness about the importance of maintaining sterile environments Growing biopharmaceutical industry. Rise in hospital-acquired infections (HAIs) |
| Opportunity | Technological advancement in bio decontamination |
| Restraint | |
Want to Explore More, Connect to our Analyst -
Segment Highlights
The equipment segment dominated the market share in 2023
By product, equipment segment dominated the market share in 2023. This is attributed to there is a growing demand for sophisticated decontamination equipment in healthcare facilities, pharmaceutical industries, and research laboratories to ensure stringent infection control and sterile environments.
The hydrogen peroxide segment dominated the market share in 2023
By agent, hydrogen peroxide segment dominated the market share in 2023. This is attributed to the fact that hydrogen peroxide is highly effective as a broad-spectrum antimicrobial agent, capable of efficiently targeting a wide range of pathogens including bacteria, viruses, fungi, and spores. Its ability to disrupt cellular processes through oxidative damage makes it a potent choice for sterilization and decontamination processes in various industries, including healthcare facilities, pharmaceutical manufacturing, and food processing.
The chamber decontamination segment dominated the market share in 2023
By type, chamber decontamination segment dominated the market share in 2023. This is attributed to the fact that chambers, such as cleanrooms and biological safety cabinets, play a critical role in maintaining sterile environments necessary for research, production, and storage of sensitive biological materials.
The pharmaceutical and Biotechnology Companies segment dominated market share in 2023
By end user, pharmaceutical and biotechnology companies segment dominated the market share in 2023. This is attributed to the fact that pharmaceutical and biotechnology companies operate within highly regulated environments were maintaining sterility and preventing contamination is crucial to ensure product quality and compliance with regulatory standards. Bio decontamination technologies offer effective solutions to sterilize equipment, facilities, and cleanrooms, thereby minimizing the risk of microbial contamination during production processes.
For Purchase Related Queries/Inquiry -
Regional Outlook
North America held a dominant position in the market in 2023 due to high adoption of the bio decontamination by biopharmaceutical companies, and well-established biopharmaceutical sector. However, the Asia-Pacific region is expected to register the highest CAGR in the forecast period. This is attributed to expanding healthcare infrastructure, increasing investments in biotechnology, and rising healthcare expenditure in countries like China, India, and Japan.
Key Players
Fedegari Autoclavi SpA Steris PLC TOMI Environmental Solutions, Inc Ecolab Inc JCE Biotechnology DIOP GmbH & Co. KG Howorth Air Technology Ltd. Zhejiang TAILIN Bioengineering Co., LTD. AM Instruments SRL Solidfog Technologies
The report provides a detailed analysis of these key players in the global Bio Decontamination market. These players have adopted different strategies such as collaboration to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Recent Developments in Bio Decontamination Market Worldwide
In July 2023, BASF SE and Recipharm, announced a collaboration. The two companies joined forces to pioneer the development of innovative ibuprofen formulations. Leveraging BASF's expertise in ibuprofen synthesis and Recipharm's proficiency in drug formulation, the partnership aims to create formulations that are more effective, exhibit fewer side effects, and are easier to administer.
Trending Reports in Healthcare Industry:
Healthcare Biometrics Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Bioreactors Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Computed Tomography (CT) Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Neonatal Ventilator Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link:
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences , Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
...
Web:
Follow Us on: LinkedIn Twitter
MENAFN04102024004107003653ID1108747113
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.